Table 1. Patient demographic information.
Agea | Sex | Tumour site | Duke's stage | Drug history | Tobacco use | Alcoholb |
---|---|---|---|---|---|---|
72 | M | Colon | B | None | No | 8+ |
68 | M | Colon | C | N/A | No | N/A |
66 | F | Colon | C1 | 5-Fluorouracil, Enalapril | No | 0 |
69 | M | Rectum | C | Co-codamol | No | 1–7 |
49 | F | Colon | B | N/A | Yes | N/A |
63 | F | Rectum | N/A | N/A | No | N/A |
52 | M | Rectum | C1 | Adalat | No | 1–7 |
75 | M | Colon | C | N/A | No | N/A |
68 | M | Colon | B | Atenolol, Prednisolone, Warfarin, Diltiazem, Isosorbide, Gliclazide, Co-danthramer | No | 1–7 |
69 | M | Rectum | C1 | Atenolol | No | 8+ |
70 | F | Rectum | B | Lithium, Thyroxine | No | 8+ |
72 | M | Rectum | B | Captopril, Naproxen, Allopurinol, Isosorbide, Frusemide, Atenolol, Prochlorperazine | No | 1–7 |
78 | M | Colon | A | N/A | No | N/A |
56 | M | Colon | A | None | No | 8+ |
76 | M | Colon | A | None | No | 1–7 |
44 | M | Colon | C | N/A | No | N/A |
58 | F | Colon | N/A | None | No | 0 |
61 | F | Rectum | A | N/A | No | N/A |
66 | F | Colon | B | None | No | 0 |
54 | M | Rectum | C1 | None | No | 1–7 |
49 | M | Colon | B | None | No | 8+ |
73 | F | Colon | B | N/A | Yes | N/A |
52 | M | Rectum | B | None | No | 8+ |
68 | M | Colon | B | Salbutamol, Ferrous sulphate | No | 0 |
63 | F | Rectum | A | Salbutamol, Beclomethasone, Bendrofluazide | No | 1–7 |
56 | M | Colon | C | Losec | No | 8+ |
68 | M | Rectum | B | Sotalol, Aspirin | No | 8+ |
80 | F | Rectum | B | None | No | 0 |
59 | M | Rectum | C1 | None | No | 8+ |
66 | M | Rectum | N/A | None | Yes | 8+ |
N/A=not available.
Age in years.
Alcohol consumption in units per week (1 unit=half a pint of beer or one glass of wine or one shot of spirits).